Abstract |
We report on the pattern of use of benoxaprofen (Opren) in a single group practice for a period which included the complete clinical life of the drug. One hundred and seventy-two patients of the 6495 practice patients had been prescribed benoxaprofen, but 55% had only a small exposure (less than 20 g). Recorded adverse reactions, of which none was serious, appeared in 25 patients. Most were taking benoxaprofen for osteoarthritis (53%) or non-specific musculoskeletal pain (39.9%). The issue of a prescription was not recorded in 19.6% of cases and 88% were on additional drugs. Greater precision in record-keeping is required to avoid problems similar to the experience with benoxaprofen.
|
Authors | P G Newrick, D Bainton |
Journal | British journal of clinical pharmacology
(Br J Clin Pharmacol)
Vol. 23
Issue 2
Pg. 195-8
(Feb 1987)
ISSN: 0306-5251 [Print] England |
PMID | 3828196
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Age Factors
- Aged
- Child
- Drug Prescriptions
- Drug Utilization
- Female
- Humans
- Male
- Middle Aged
- Osteoarthritis
(drug therapy)
- Propionates
(adverse effects, therapeutic use)
- Risk
- United Kingdom
|